| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |